Atypical presentations of neuromyelitis optica.

Neuromyelitis optica (NMO) is an inflammatory disease of central nervous system classically characterized by acute, severe episodes of optic neuritis and longitudinally extensive transverse myelitis, usually with a relapsing course. The identification of an autoantibody exclusively detected in NMO patients against aquaporin-4 (AQP-4) has allowed identification of cases beyond the classical phenotype. Brain lesions, once thought as infrequent, can be observed in NMO patients, but lesions have different characteristics from the ones seen in multiple sclerosis. Additionally, some AQP-4 antibody positive patients may present with a variety of symptoms not being restricted to optic neuritis and acute myelitis during the first attack or in a relapse. Examples are not limited to, but may include patients only with brain and/or brainstem lesions, narcolepsy with hypothalamic lesions or patients with intractable hiccups, nausea and vomiting. The prompt identification of NMO patients with atypical presentations may benefit these patients with institution of early treatment to reduce disability and prevent further attacks.

[1]  M. Go,et al.  Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics. , 2012, Archives of neurology.

[2]  S. Weigand,et al.  Neuromyelitis optica unique area postrema lesions , 2011, Neurology.

[3]  K. Fujihara,et al.  Neuromyelitis optica without typical opticospinal phenotype , 2010, Multiple sclerosis.

[4]  K. Fujihara,et al.  Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity , 2010, Multiple sclerosis.

[5]  Y. Itoyama,et al.  Neuromyelitis optica preceded by hyperCKemia episode , 2010, Neurology.

[6]  J Grimaud,et al.  Neuromyelitis optica in France , 2010, Neurology.

[7]  P. Marchiori,et al.  Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics , 2010, Multiple sclerosis.

[8]  T. Shimohata,et al.  Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. , 2009, Archives of neurology.

[9]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[10]  S. Sakoda,et al.  Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. , 2009, Biochemical and biophysical research communications.

[11]  Y. Itoyama,et al.  Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody , 2009, Journal of Neurology.

[12]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[13]  Y. Itoyama,et al.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.

[14]  B. Weinshenker,et al.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. , 2006, Archives of neurology.

[15]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[16]  B. Weinshenker,et al.  Brain abnormalities in neuromyelitis optica. , 2006, Archives of neurology.

[17]  Y. Itoyama,et al.  Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica , 2005, Neurology.

[18]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[19]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[20]  Y. Itoyama,et al.  Eugène Devic (1858–1930) , 2002, Journal of Neurology.

[21]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[22]  R. Sergott “Cloud-like Enhancement” Is a Magnetic Resonance Imaging Abnormality Specific to Neuromyelitis Optica , 2010 .

[23]  R. Gross Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study , 2010 .